X

Trial Profile

Assessment of Anatomical and Functional Outcomes in Patients Treated With Ocriplasmin for Vitreomacular Traction/Symptomatic Vitreomacular Adhesion (VMT/sVMA)

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 13 Dec 2022

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Ocriplasmin (Primary)
Indications Retinal disorders; Retinal perforations
Focus Therapeutic Use
Acronyms OVIID-I
Sponsors Alcon

Most Recent Events

07 Sep 2016 Results from this trial will be presented at the EURETINA Annual Conference 2016, according to a ThromboGenics media release.
27 Apr 2016 According to ThromboGenics media release, company will present data from this study at the upcoming Association for Research in Vision and Ophthalmology (ARVO) 2016 Annual Meeting.
10 Sep 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com